GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » EBIT

Benchmark Holdings (LSE:BMK) EBIT : £-7.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings EBIT?

Benchmark Holdings's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2023 was £-4.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Benchmark Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -4.55%. Benchmark Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -12.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Benchmark Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.95%.


Benchmark Holdings EBIT Historical Data

The historical data trend for Benchmark Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings EBIT Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -52.39 -14.20 -1.19 -10.13 -2.19

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.91 1.21 -1.89 -2.75 -4.51

Competitive Comparison of Benchmark Holdings's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's EV-to-EBIT falls into.



Benchmark Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was £-7.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings  (LSE:BMK) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Benchmark Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=-16.644 * ( 1 - -6.02% )/( (403.363 + 372.559)/ 2 )
=-17.6459688/387.961
=-4.55 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Benchmark Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-18.024/( ( (93.215 + max(41.603, 0)) + (88.177 + max(59.459, 0)) )/ 2 )
=-18.024/( ( 134.818 + 147.636 )/ 2 )
=-18.024/141.227
=-12.76 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(24.848 + 52.855 + 18.931) - (31.407 + 0 + 23.624)
=41.603

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(56.38 + 44.431 + 0.49999999999999) - (39.442 + 0 + 2.41)
=59.459

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Benchmark Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-7.943/407.808
=-1.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines